Home Melt Pharmaceuticals

Melt Pharmaceuticals

acquired
Series B
Analgesic Drug Developer

Basic Information

Melt Pharmaceuticals, Inc., headquartered in Nashville, Tennessee, is dedicated to developing and commercializing patented sublingual, needle-free, and opioid-free procedural sedation and analgesic drugs to improve the experience of patients undergoing ophthalmic surgeries. Our novel patented fast-dissolving sublingual tablets provide a needle-free and opioid-free solution for both patients and caregivers.
Melt Pharmaceuticals, Inc.
Nashville,Tennessee,United States of America
less than 15 people
January 01, 2019
info@meltpharma.com